Surgalign Holdings, Inc. SRGA
We take great care to ensure that the data presented and summarized in this overview for SURGALIGN HOLDINGS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SRGA
Top Purchases
Top Sells
About SRGA
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Insider Transactions at SRGA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2023
|
David Lyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-1.57%
|
$0
$0.01 P/Share
|
Sep 01
2023
|
Paolo Amoruso Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,191
-7.07%
|
$0
$0.01 P/Share
|
Aug 15
2023
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
5,541
-17.56%
|
$0
$0.02 P/Share
|
Aug 15
2023
|
Christopher Thunander Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,295
-8.1%
|
$0
$0.02 P/Share
|
Aug 15
2023
|
David Lyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,072
-8.71%
|
$0
$0.02 P/Share
|
Aug 15
2023
|
Marc E. Mackey EVP, Digital Surgery |
SELL
Payment of exercise price or tax liability
|
Direct |
4,589
-9.39%
|
$0
$0.02 P/Share
|
Aug 15
2023
|
Terry M. Rich President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,821
-5.57%
|
$0
$0.02 P/Share
|
Aug 07
2023
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.33%
|
$0
$0.02 P/Share
|
Aug 07
2023
|
Christopher Thunander Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-0.09%
|
$0
$0.02 P/Share
|
Aug 07
2023
|
Terry M. Rich President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
446
-0.28%
|
$0
$0.02 P/Share
|
Jun 15
2023
|
David Lyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,330
-1.41%
|
$1,330
$1.18 P/Share
|
May 07
2023
|
Terry M. Rich President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
686
-0.22%
|
$686
$1.2 P/Share
|
May 07
2023
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.33%
|
$106
$1.2 P/Share
|
May 07
2023
|
William Scott Durall Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.28%
|
$178
$1.2 P/Share
|
Mar 31
2023
|
William Scott Durall Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
145
-0.23%
|
$145
$1.6 P/Share
|
Mar 15
2023
|
David Lyle Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,438
-5.47%
|
$5,438
$1.75 P/Share
|
Feb 26
2023
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
209
-0.65%
|
$209
$1.77 P/Share
|
Feb 07
2023
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.33%
|
$212
$2.14 P/Share
|
Feb 07
2023
|
Terry M. Rich President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-0.34%
|
$1,080
$2.14 P/Share
|
Feb 07
2023
|
William Scott Durall Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.28%
|
$356
$2.14 P/Share
|